RU93046317A - Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции - Google Patents

Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции

Info

Publication number
RU93046317A
RU93046317A RU93046317/14A RU93046317A RU93046317A RU 93046317 A RU93046317 A RU 93046317A RU 93046317/14 A RU93046317/14 A RU 93046317/14A RU 93046317 A RU93046317 A RU 93046317A RU 93046317 A RU93046317 A RU 93046317A
Authority
RU
Russia
Prior art keywords
chondroitinase abc
amino acid
terminal amino
chindroitinase
contents
Prior art date
Application number
RU93046317/14A
Other languages
English (en)
Other versions
RU2144833C1 (ru
Inventor
Хосимота Нобуказу
Матизуки Хидео
Хамаи Акио
Исикава Синити
Торикаи Мисако
Мияти Исао
Original Assignee
Сейкагаку Когио Кабусики Кайся (Сейкагаку Корпорейшн)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP31098092A external-priority patent/JP3895782B2/ja
Application filed by Сейкагаку Когио Кабусики Кайся (Сейкагаку Корпорейшн) filed Critical Сейкагаку Когио Кабусики Кайся (Сейкагаку Корпорейшн)
Publication of RU93046317A publication Critical patent/RU93046317A/ru
Application granted granted Critical
Publication of RU2144833C1 publication Critical patent/RU2144833C1/ru

Links

Claims (1)

  1. Кристаллизующаяся очищенная хондроитиназа ABC с молекулярной массой около 100000 получена методом электрофореза с использованием додецилсульфата натрия - полиакриламидного геля (SDS - PAGE) и методом гельпроникающей хроматографии содержит аланин в качестве N -концевой аминокислоты и пролин в качестве C - концевой аминокислоты. Способ очистки кристаллизующейся очищенной хондроитиназы ABC включает удаление нуклеиновой кислоты раствором поверхностно-активного вещества из экстракта, полученного из клеток микроорганизмов, продуцирующих хондроитиназу ABC, и хроматографирование при градиентном концентрированном элюировании с применением слабой катионо-обменной смолы или сильной катионо-обменной смолы. Композиция включает зондроитиназу и сывороточный альбумин, желатин или неионное поверхностно-активное вещество.
RU93046317A 1992-06-26 1993-06-25 Хондроитиназа, способ ее получения и включающие ее фармацевтические композиции RU2144833C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP192882/1992 1992-06-26
JP19288292 1992-06-26
JP310980/1992 1992-10-26
JP31098092A JP3895782B2 (ja) 1992-10-26 1992-10-26 コンドロイチナーゼ組成物およびそれを含有する注射用製剤

Publications (2)

Publication Number Publication Date
RU93046317A true RU93046317A (ru) 1996-05-20
RU2144833C1 RU2144833C1 (ru) 2000-01-27

Family

ID=26507572

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93046317A RU2144833C1 (ru) 1992-06-26 1993-06-25 Хондроитиназа, способ ее получения и включающие ее фармацевтические композиции

Country Status (10)

Country Link
US (3) US5496718A (ru)
EP (1) EP0576294B1 (ru)
KR (1) KR100280779B1 (ru)
AT (1) ATE192486T1 (ru)
CA (1) CA2099138C (ru)
DE (1) DE69328519T2 (ru)
DK (1) DK0576294T3 (ru)
ES (1) ES2146600T3 (ru)
RU (1) RU2144833C1 (ru)
SG (1) SG50677A1 (ru)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496718A (en) * 1992-06-26 1996-03-05 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Chondroitinase ABC isolated from proteus vulgaris ATCC 6896
JP3419811B2 (ja) * 1993-02-24 2003-06-23 マルハ株式会社 コンドロイチナーゼ遺伝子
US7008783B1 (en) 1992-09-22 2006-03-07 Maruha Corporation Gene encoding chondroitinase ABC and uses therefor
AU697156B2 (en) * 1993-04-23 1998-10-01 American Cyanamid Company Cloning and expression of the chondroitinase I and II genes from (p. vulgaris)
AU1176595A (en) * 1993-11-12 1995-05-29 International Technology Management Associates, Ltd. Methods of repairing connective tissues
US5525500A (en) * 1994-04-22 1996-06-11 American Cyanamid Company Chromatographic process for the copurification of chondroitinase I and II proteins from Proteus vulgaris
US5498536A (en) * 1994-04-22 1996-03-12 American Cyanamid Company Chondroitinase II from Proteus vulgaris
EP0756636A4 (en) * 1994-04-22 1997-12-17 American Cyanamid Co CHONDROITINASES I AND II, PROCESSES FOR THEIR PREPARATION AND THEIR USE
US5888798A (en) * 1995-06-07 1999-03-30 American Cyanamid Company Chondroitinase I and chondroitinase II producing mutants of P. vulgaris
EP0747469A1 (en) 1995-06-08 1996-12-11 The Procter & Gamble Company Cleaning compositions comprising chondroitinase
DE69829605T2 (de) * 1997-05-02 2006-02-09 Seikagaku Corp. Chondroitinase enthaltende Zusammensetzungen
JPH1149698A (ja) 1997-07-31 1999-02-23 Santen Pharmaceut Co Ltd 安定性を向上させたラクトフェリンの水性製剤
ES2185117T3 (es) * 1997-08-22 2003-04-16 Seikagaku Kogyo Co Ltd Agente terapeutico para disco intervertebral herniado.
TWI245645B (en) 1999-09-08 2005-12-21 Chugai Pharmaceutical Co Ltd Protein solution formulations and stabilization methods thereof
JP4252892B2 (ja) 2001-06-01 2009-04-08 三菱製紙株式会社 全熱交換素子用紙
CA2455827C (en) 2001-08-13 2015-06-09 University Of Florida Research Foundation, Inc. Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan
GB0205022D0 (en) 2002-03-04 2002-04-17 Univ Cambridge Tech Materials and methods for the treatment of cns damage
EP1575548B1 (en) * 2002-05-04 2011-03-09 Acorda Therapeutics, Inc. Compositions and methods for promoting neuronal outgrowth
WO2003102160A2 (en) * 2002-06-03 2003-12-11 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from chondroitinase b
DE60337009D1 (de) * 2002-08-15 2011-06-16 Acorda Therapeutics Inc Chimärisches protein
US7544499B2 (en) * 2002-12-16 2009-06-09 Halozyme, Inc. Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
EP2330213A1 (en) 2003-03-05 2011-06-08 Halozyme, Inc. Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
US20090123367A1 (en) * 2003-03-05 2009-05-14 Delfmems Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
EP3211084B1 (en) 2003-05-16 2019-03-27 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of cns
MXPA05012305A (es) * 2003-05-16 2006-04-18 Acorda Therapeutics Inc Composiciones y metodos para el tratamiento de lesiones del snc.
US7959914B2 (en) 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
RU2259350C2 (ru) * 2003-07-14 2005-08-27 Открытое акционерное общество "Пигмент" Способ получения анилина и/или n-метиланилина и катализатор для него
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
CA2558984A1 (en) * 2004-03-10 2005-09-22 Massachusetts Institute Of Technology Recombinant chondroitinase abc i and uses thereof
AU2005244933B2 (en) * 2004-05-18 2011-08-04 Acorda Therapeutics, Inc. Methods of purifying chondroitinase and stable formulations thereof
WO2005122734A2 (en) * 2004-06-14 2005-12-29 The Research Foundation Of State University Of New York Nanosphere/microsphere delivery system for the treatment of spinal cord injury
EP1848812A4 (en) * 2004-10-01 2011-11-09 Life Technologies Corp SUPPLY BUFFERS, SYSTEMS AND METHODS FOR THE IN VITRO SYNTHESIS OF BIOMOLECULES
RU2275190C1 (ru) * 2005-04-06 2006-04-27 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Средство для лечения болезней суставов
JP5189985B2 (ja) 2005-09-26 2013-04-24 アコーダ セラピューティクス、インク． コンドロイチナーゼａｂｃｉ変異体を用いた組成物およびその使用方法
US8003369B2 (en) 2005-11-29 2011-08-23 Sanyo Chemical Industries, Ltd. Bacteriolytic agent
AU2007307736C1 (en) 2006-10-10 2014-04-10 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase ABCI mutants
JP5341756B2 (ja) 2007-06-29 2013-11-13 国立大学法人名古屋大学 神経障害に基づく機能不全の改善剤およびＲｈｏキナーゼ活性化抑制剤
US20090286289A1 (en) * 2008-03-10 2009-11-19 Pang Danny Z Production of Hyaluronate Unsaturated Disaccharides and its Application
DK2653168T3 (da) * 2010-12-13 2015-04-20 Seikagaku Kogyo Co Ltd Chondroitinase-abc til behandling af diskusprolaps
JP6580581B2 (ja) 2014-09-27 2019-09-25 大日本住友製薬株式会社 注射用医薬組成物
US9796970B1 (en) 2017-04-24 2017-10-24 Advantek Serum Laboratories Ltd. Production of high purity chondroitinase ABC
EP4512425A3 (en) 2018-02-28 2025-05-21 Seikagaku Corporation Package and method for producing the same
TW202513090A (zh) 2018-02-28 2025-04-01 日商生化學工業股份有限公司 醫藥組成物、包裝體及其製造方法
EP4175969A4 (en) * 2020-07-01 2024-07-24 Medimmune, LLC DETERGENT AND METHOD FOR PURIFYING A BIOTHERAPY AGENT
CN114409731B (zh) * 2022-01-05 2023-08-11 浙江省农业科学院 同时具有激活乙醇脱氢酶和乙醛脱氢酶活性的两种多肽

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549500A (en) * 1967-07-22 1970-12-22 Seikagaku Kogyo Co Ltd Novel chondroitinase and method of its recovery
JPS4832351B1 (ru) * 1968-06-12 1973-10-05
JPS4713704Y1 (ru) * 1971-09-29 1972-05-18
JPS6031479B2 (ja) * 1978-02-10 1985-07-22 生化学工業株式会社 純コンドロイチナ−ゼｃの製造法
JPS6031478B2 (ja) * 1978-02-10 1985-07-22 生化学工業株式会社 純コンドロイチナ−ゼｂの製造法
EP0009781B2 (en) * 1978-09-29 1986-04-23 Mitsubishi Kasei Corporation Process for the purification of long-chain acyl-coenzyme-a synthetase and the enzyme, acyl-coa synthetase, purified thereby
CA1221328A (en) * 1983-04-21 1987-05-05 Robert K. Scopes Enzyme extraction and purification processes
US4696816A (en) * 1985-11-07 1987-09-29 Brown Mark D Method for treating intervertebral disc displacement with enzymes
JPS62122588A (ja) * 1985-11-22 1987-06-03 Taiyo Fishery Co Ltd 純コンドロイチナ−ゼの製造法
JP2726275B2 (ja) * 1988-08-24 1998-03-11 生化学工業株式会社 グリコサミノグリカン分解酵素の精製法
JP2919496B2 (ja) * 1989-08-24 1999-07-12 生化学工業株式会社 新規コンドロイチン硫酸分解酵素、それらを産生する微生物並びにそれらの製法
JP3140797B2 (ja) * 1991-04-26 2001-03-05 生化学工業株式会社 安定化コンドロイチナーゼａｂｃ、その保存方法及び治療剤
US5496718A (en) * 1992-06-26 1996-03-05 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Chondroitinase ABC isolated from proteus vulgaris ATCC 6896

Similar Documents

Publication Publication Date Title
CA2099138A1 (en) Chondroitinase, Process for Preparing the Same, and Pharmaceutical Composition Comprising the Same
Dimuzio et al. Phosphophoryns—major noncollagenous proteins of rat incisor dentin
AU698334B2 (en) Method for isolation of highly pure von willebrand factor
Yonemasu et al. Chemical studies on Clq; a modulator of immunoglobulin biology
Calvete et al. A procedure for the large-scale isolation of major bovine seminal plasma proteins
Morris et al. Characterization of monellin, a protein that tastes sweet
Bailey et al. Partial characterization of a second basement membrane collagen in human placenta: evidence for the existence of two type IV collagen molecules
Joubert Snake venom toxins: The amino acid sequences of two toxins from Ophiophagus hannah (King Cobra) venom
EP1111053A3 (fr) Fragment peptidique de la protéine g du virus respiratoire syncytial, agent immunogène, composition pharmaceutique le contentant et procédé de préparation
IE860305L (en) Method for purifying antihemophilic factor
US4672108A (en) Crystalline human leukocyte interferon
NZ509135A (en) A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods
Rathnam et al. Subunits of luteinizing hormone from human pituitary glands
JPS63503352A (ja) タンパク質の精製
KR860004149A (ko) 재조합 dna 기술에 의해 제조된 생리적 활성 물질의 정제방법
PH24961A (en) Monocional antibodies for human non-small cell lung carcinomas
Lopez et al. The complete amino acid sequence of human complex-forming glycoprotein heterogeneous in charge (protein HC)
DK0419878T3 (da) Nye aprotinin-varianter og genteknologisk fremgangsmåde til mikrobiel fremstilling af disse varianter i homogent processeret form
Sugiyama et al. Isolation and characterization of histamine-releasing peptides from human parotid saliva
JPS59231097A (ja) 均質ヒト免疫インターフェロンサブタイプ２１ｋおよびその製造法
Takahashi et al. Purification and characterization of anticomplement factor (cobra venom factor) from the Naja naja atra venom
Swart et al. Studies on the high-sulphur proteins of reduced Merino wool. Amino acid sequence of protein SCMKB-IIIB4
IE821249L (en) Peptides
Stepanik et al. Primary structure of human alpha 2-macroglobulin. III. Primary structure of three large disulfide-bridged CNBr fragments, located in the COOH-terminal part of alpha 2-macroglobulin and accounting for 301 residues.
Taroh et al. Eighth component of guinea pig complement: Purification and characterization